$FOLD
Amicus Therapeutics Inc.
PRICE
$21.8 ▼-0.16%
Extented Hours
VOLUME
4,221,580
DAY RANGE
21.79 - 23.36
52 WEEK
6.63 - 24.89
Echofin Members Consensus
coulldc #vpatraders Join team
Hi @Mbstok and welcome back to the fold and we are still very much forex focused - we run two webinars at the moment, the one in the morning is the London open and forex specific and we do have futures also but both spot and futures,. Spot markets are just the same as they always have been - we have just added futures to show that VPA applies equally well to both. The second webinar for the US session is more index/
Key Metrics
Market Cap
5.69 B
Beta
1.40
Avg. Volume
2.43 M
Shares Outstanding
260.59 M
Yield
0%
Public Float
0
Next Earnings Date
Next Dividend Date
Company Information
CEO: John Crowley
Website: http://www.amicusrx.com/
HQ: 1 Cedarbrook Dr Cranbury, 08512-3618 New jersey
Related News
-
Sarepta, Amicus Top Biotech Picks Ahead Of Key Binary Events: Analyst
18 Dec 2020, 19:00 -
Hung Do Sells 111,125 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) Stock
18 Dec 2020, 10:20 -
A Look At The Intrinsic Value Of Amicus Therapeutics, Inc. (NASDAQ:FOLD)
14 Dec 2020, 11:50 -
The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut
03 Dec 2020, 12:46 -
The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted
18 Nov 2020, 12:29